UK Home Academics Athletics Medical Center Research Site Index Search UK
Researcher with Graduate Student College of Medicine Department Logo  
click here to view a link
Dr. Spear

Department of Microbiology, Immunology and Molecular Genetics

Brett Spear, Ph.D.

Professor

Doctoral studies: University of Pennsylvania.

Postdoctoral: Princeton University.

Member of:
Graduate Center for Toxicology
Graduate Center for Nutritional Sciences
Integrated Biomedical Sciences (IBS) Graduate Program

Dr. Spear

Office phone: (859)257-5167
Fax: (859)257-8994
Lab phone: (859)323-5089

Email

Selected publications

Genomics Seminar

Research statement: My research interests are in the area of mammalian gene regulation; in particular, we are interested in transcriptional regulation in the liver during development and disease. Two experimental systems are being used for these studies. First, liver-specific regulation of the mouse alpha-fetoprotein (AFP) gene is being investigated using biochemical and molecular genetic strategies in tissue culture cells and transgenic mice. In vitro biochemical studies allow us to characterize the interplay between transcription factors and AFP regulatory elements such as the AFP promoter and enhancers. AFP constructs are analyzed in liver cell lines to further explore the consequences of these interactions. Finally, to fully understand aspects of AFP regulation, we introduce AFP DNA constructs into the mouse germline to produce transgenic animals. Using the tools and resources of the human genome project, we are also using a genetic approach to clone Afr1, a regulator of AFP expression. Our long-term objective is to understand the complex processes that control gene expression during mammalian development and will ultimately elucidate how specific organs such as the liver arise from a precursor cell population. 

We are also interested in how transcription factors are involved in the response to agents that cause liver damage and/or liver cancer. In particular, we are studying the response to peroxisome proliferators, phenobarbital, and PCBs. We have focused on the link between these chemicals, oxidative stress, and the transcription factor NF-kB. Using transgenic and gene knock-out mice, we are using methods to block NF-kB activation specifically in the liver. These mice provide an in vivo model system to study the role of NF-kB in hepatocarcinogenesis and the response to liver-damaging agents.


.

Search COM
 
Comments to Jeff Lynn, Last Modified: Tuesday, October 03, 2006
Copyright © 2004, University of Kentucky Chandler Medical Center
Terms, Conditions & Privacy Statement
An Equal Opportunity University